CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Carmel Diagnostics has developed a system for assessing oxidative stress in body fluids, aimed at improving embryo selection in IVF and risk stratification for heart failure patients. This technology offers a non-invasive biomarker solution.
Abstract:Carmel Diagnostics, established in 2009, is an SME that has developed clinical applications of its novel, proprietary, patented Thermochemiluminescence technology platform – TCL Analyzer™.
Carmel has successfully completed “proof of concept” for its main applications:
Embryo Selection in IVF process and Risk Stratification for CHF patients.
The results were published in leading magazines.
The technology enables assessment of Oxidative Stress in body fluids using it as a biomarker for cl…
CARMEL DIAGNOSTICS LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
